about
Anaphylaxis and hypotension after administration of peginesatideRelationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients.Body composition and survival in dialysis patients: results from an international cohort study.Seasonal variations in mortality, clinical, and laboratory parameters in hemodialysis patients: a 5-year cohort study.Seasonal variations in mortality and clinical indicators in international hemodialysis populations from the MONDO registryNutritional Competence and Resilience among Hemodialysis Patients in the Setting of Dialysis Initiation and HospitalizationHemodialysis outcomes in a global sample of children and young adult hemodialysis patients: the PICCOLO MONDO cohortInterdialytic weight gain, systolic blood pressure, serum albumin, and C-reactive protein levels change in chronic dialysis patients prior to deathThe evils of intradialytic sodium loading.Vascular access vulnerability in intensive hemodialysis: a significant Achilles' heel?The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation.IMPACT OF THE KARNOFSKY PERFORMANCE STATUS ON SURVIVAL AND ITS DYNAMICS DURING THE TERMINAL YEAR OF PERITONEAL DIALYSIS PATIENTS.Implementation of routine foot check in patients with diabetes on hemodialysis: associations with outcomes.Season affects body composition and estimation of fluid overload in haemodialysis patients: variations in body composition; a survey from the European MONDO database.Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).Inflammation and premature aging in advanced chronic kidney disease.To cool, or too cool: Is reducing dialysate temperature the optimal approach to preventing intradialytic hypotension?Effects of renal care coordinator case management on outcomes in incident dialysis patients.Plasma Gelsolin and Its Association with Mortality and Hospitalization in Chronic Hemodialysis Patients.A year-long quality improvement project on fluid management using blood volume monitoring during hemodialysis.Monitoring dialysis outcomes across the world--the MONDO Global Database Consortium.Periodontal disease adversely affects the survival of patients with end-stage renal disease.The MONitoring Dialysis Outcomes (MONDO) initiative.Variability of predialytic, intradialytic, and postdialytic blood pressures in the course of a week: a study of Dutch and US maintenance hemodialysis patients.Right TraC™ Post-Hospitalization Care Transitions Program to Reduce Readmissions for Hemodialysis Patients.Performance of the Surprise Question Compared to Prediction Models in Hemodialysis Patients: A Prospective Study.Association between pre hemodialysis serum sodium concentration and blood pressure: results from a retrospective analysis from the international monitoring dialysis outcomes (MONDO) initiative.Impact of fluid status and inflammation and their interaction on survival: a study in an international hemodialysis patient cohort.Clinical parameters before and after the transition to dialysis.Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance.Dynamics of Nutritional Competence in the Last Year Before Death in a Large Cohort of US Hemodialysis Patients.Fluid dynamics during hemodialysis in relationship to sodium gradient between dialysate and plasma.Dialysis Access as an Area of Improvement in Elderly Incident Hemodialysis Patients: Results from a Cohort Study from the International Monitoring Dialysis Outcomes Initiative.Unraveling the relationship between mortality, hyponatremia, inflammation and malnutrition in hemodialysis patients: results from the international MONDO initiative.Depressive affect in incident hemodialysis patients.The Association of Weekly pre-Hemodialysis Systolic Blood Pressure and Following Week Mortality.No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure.Relation between trends in body temperature and outcome in incident hemodialysis patients.Associations between global population health indicators and dialysis variables in the Monitoring Dialysis Outcomes (MONDO) consortium.Hospitalization and mortality in hemodialysis patients: association with hemoglobin variability.
P50
Q34357203-B5C7D28B-87B1-4501-AEBB-8876B5DA05C8Q34570994-D8C8E266-4F7A-42EC-928F-97BEF9E03AC3Q35611214-CC1AE311-C394-4C5D-831B-1C381B964C79Q35692494-BBBB6982-89D0-4EC9-AAA7-4CB6B2E2D86BQ35745490-254A3CBA-1869-4ABB-B682-75D96932DAF8Q36025639-0D7E2A38-D00E-4146-B0CD-FDE64410B89AQ36689213-E2C9A184-9849-405D-A9A6-825B5251AB04Q36968792-E05D68AF-CF32-4C1C-98CD-5265E70C0702Q37882275-AB133E63-637C-4FCE-927B-EFF317F7F933Q38218003-B3B349A8-436D-48F8-87F0-CC0325535BECQ38603433-785B06A4-2B30-46E1-9FFB-9AFBE96A1122Q38648098-1B926EF6-DABC-44F3-ADD6-B16904506ACCQ38804703-DFF08222-EFEE-4903-BC27-2FBCE94B38D7Q39078436-76B2CE32-E7B6-4982-9C33-FC8508204A59Q39170694-BF6988E1-AA1F-4885-A9E1-509D153BB388Q39309490-DD6AA637-E03C-4588-B1A9-8253988005A3Q39407364-44D20F5D-630F-4A8D-A72D-A7F92070DF4AQ40034951-2AA1C8A7-B9B7-48AF-A07B-36A680E1259FQ40368335-296AB8FA-4BF6-4846-BD03-886DC11E0392Q40975363-79DAC514-BC8D-45BA-A2E1-4FCFA7743B0CQ42641443-0A6AEAE2-0036-445B-94AD-51BBEDD80369Q43643048-53859B63-BEF0-4749-8FC5-2B9F089E6B3AQ44258186-0DF3E06B-A9E7-4175-957B-8D50BF6B1C58Q44652189-A7851E5F-ED2A-4F04-910F-B37666A21254Q46039627-7A0B6319-F599-454B-A318-7C846F58E359Q46179751-5CFA4F10-B451-4D8D-A234-B60E86C515DDQ46203158-1BB711B4-B421-4322-81C3-4BA0015FB947Q46222904-FD2725DE-0FD8-4AE1-8064-2BB5DCEAA399Q47578188-EBD7A870-3D4B-413A-94B5-EA1DC7B123D5Q47579842-49A82274-DCB5-4585-9B6E-A0D49855F22DQ47752352-B0530A6F-95A4-4B9C-99B0-DCE8586AC04FQ48400201-F649CED8-4D21-47BE-85A2-140AC25C152DQ48648815-E7B4842E-3939-43BF-B298-7EF42A944945Q48825527-CECC4AC9-D84E-44F9-88DC-DCE1E0C59C9EQ49279915-EB724FD1-71FA-4519-A1C0-FA0A11070824Q50133976-707FC784-666B-44CF-B36E-78307B32AB93Q50526346-60F8DA17-A79D-4245-9805-F68B4BF5310DQ50946804-A784FA61-6DF3-496C-9EFB-CC53851DE0CFQ50961407-D0581A9B-151F-4E77-8BD0-E3FD6619BF13Q50978270-FCE8198C-0A34-4C9A-A53B-6D0E6D58A6CE
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Len Usvyat
@ast
Len Usvyat
@en
Len Usvyat
@es
Len Usvyat
@nl
Len Usvyat
@sl
type
label
Len Usvyat
@ast
Len Usvyat
@en
Len Usvyat
@es
Len Usvyat
@nl
Len Usvyat
@sl
prefLabel
Len Usvyat
@ast
Len Usvyat
@en
Len Usvyat
@es
Len Usvyat
@nl
Len Usvyat
@sl
P106
P1153
6507903339
P31
P496
0000-0003-2745-1429